Leaderboard 10.6.2025

News About AbbVie

9 press releases

The Countdown Is On: BOTOX® Cosmetic (onabotulinumtoxinA) Day is Back Nov. 18

October 28, 2026

AbbVie Partners with Valkai to Apply Advanced AI Across Targeted Areas of Clinical Development

September 29, 2026

U.S. FDA Approves AbbVie's JUVMO™ (tavapadon) for Parkinson's Disease

September 28, 2026

AbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discovery

September 21, 2026

AbbVie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine

September 10, 2026

AbbVie Completes Acquisition of Apogee Therapeutics

September 03, 2026

SkinMedica® Adds Barrier Calming Cream to its Collection of Regenerative Skincare Offerings

September 01, 2026

AbbVie to Present New Data at WCLC 2026 Showcasing Innovation Across Lung Cancer Pipeline

August 21, 2026

AbbVie Announces 2026 AbbVie Immunology Scholarship Recipients, Celebrating 10 Years of Support

August 18, 2026